Search

Your search keyword '"Roberto Miccoli"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Roberto Miccoli" Remove constraint Author: "Roberto Miccoli" Language english Remove constraint Language: english
46 results on '"Roberto Miccoli"'

Search Results

1. Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report

2. Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report

3. Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study

4. Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory

5. Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge

6. Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus

7. Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line.

8. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I

9. Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge

10. A view on the quality of diabetes care in Italy and the role of Diabetes Clinics from the 2018 ARNO Diabetes Observatory

11. Invited review. Series: Implications of the recent CVOTs in type 2 diabetes: Which patients for GLP-1RA or SGLT-2 inhibitor?

12. Clinical burden of diabetes in Italy in 2018: A look at a systemic disease from the ARNO Diabetes Observatory

13. Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study

14. Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus

16. The relative burden of diabetes complications on healthcare costs: The population-based ARNO Diabetes Observatory, Italy

17. Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line

18. Feasibility and Effectiveness in Clinical Practice of a Multifactorial Intervention for the Reduction of Cardiovascular Risk in Patients With Type 2 Diabetes

19. Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012

20. Pathogenetic Mechanisms and Cardiovascular Risk

21. New forms of insulin and insulin therapies for the treatment of type 2 diabetes

22. Access to emergency room for hypoglycaemia in people with diabetes

23. Optimal therapy of type 2 diabetes: a controversial challenge

24. Lipoprotein Glomerulopathy: molecular chatacterization of three Italian patients and literature survey

25. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients

26. The Global Cardiovascular Risk Transition: Associations of Four Metabolic Risk Factors with Macroeconomic Variables in 1980 and 2008

27. Insulin as an early treatment for type 2 diabetes

28. PPARG2 Pro12Ala and ADAMTS9 rs4607103 as 'insulin resistance loci' and 'insulin secretion loci' in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4

29. Pleiotropic Effects of GIP on Islet Function Involves Osteopontin

30. 2009 SIPREC consensus document executive summary: Cardiovascular prevention in subjects with impaired fasting glucose or impaired glucose tolerance

31. POSTPRANDIAL HYPERGLYCEMIA IS A DETERMINANT OF PLATELET ACTIVATION IN EARLY 2 DIABETES MELLITUS

32. Prognostic implications of diabetes phenotyping: new concepts for an old disease

33. Changing the treatment paradigm for type 2 diabetes

35. Insulin Resistance and Lipid Disorders

36. Optimizing management of metabolic syndrome to reduce the risk: focus on life-style

37. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome

38. Pharmacological intervention in prediabetes: considering the risks and benefits

39. Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes

40. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

41. Hyperglycaemia and cardiovascular risk

42. Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency

43. Prevalence and risk factors for gestational diabetes assessed by universal screening

44. Effects of pravastatin treatment on lipoprotein levels and composition in patients with type 2 diabetes mellitus and hypercholesterolemia

45. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I

46. Genetically determined absence of HDL-cholesterol and coronary atherosclerosis

Catalog

Books, media, physical & digital resources